✦ LIBER ✦

Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer

✍ Scribed by Pan, K.; Guan, X.-X.; Li, Y.-Q.; Zhao, J.-J.; Li, J.-J.; Qiu, H.-J.; Weng, D.-S.; Wang, Q.-J.; Liu, Q.; Huang, L.-X.; He, J.; Chen, S.-P.; Ke, M.-L.; Zeng, Y.-X.; Xia, J.-C.

Book ID: 124052159
Publisher: American Association for Cancer Research
Year: 2014
Tongue: English
Weight: 335 KB
Volume: 20
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-14-0082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of adjuvant immunotherapy with

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer

✍ Liangrong Shi, Qi Zhou, Jun Wu, Mei Ji, Guojun Li, Jingting Jiang, Changping Wu 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 337 KB

Efficacy of postoperative adjuvant trans

Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer

✍ Zhu, Yanjuan; Zhang, Haibo; Li, Yong; Bai, Jianping; Liu, Lirong; Liu, Yihong; Q 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 371 KB

Clinical Implication of p53 Overexpressi

Clinical Implication of p53 Overexpression in Breast Cancer Patients Younger than 50 Years with a Triple-negative Subtype Who Undergo a Modified Radical Mastectomy

✍ Lee, D.-S.; Kim, S. H.; Suh, Y. J.; Kim, S.; Kim, H. K.; Shim, B. Y. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 218 KB

Increased natural killer cell activity c

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer

✍ C. Wiltschke; E. Tyl; P. Speiser; A. Steininger; R. Zeillinger; F. Kury; K. Czer 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

Selections of appropriate regimen of hig

Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences

✍ Jun Ren, Lijun Di, Guohong Song, Jing Yu, Jun Jia… 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 336 KB

Final results of a multicenter phase II

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

✍ Marta Pestrin, Silvia Bessi, Fabio Puglisi, Alessandro M. Minisini, Giovanna Mas 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 246 KB